All the Active Ingredient Drugs
Corticosteroid, β2 Agonist. Beclometasone Dipropionate 100 mcg/metered dose, 200 mcg/metered dose, Formoterol Fumarate (dihydrate) 6 mcg/metered dose. INHALER.(pressurised sol. for inhal.):1×120 actuat.
Asthma: Maint. therapy for pts. 18 yrs. and above- 1, 2 inhal. ×2/d. max. dly. dose is 4 inhal. Maint. & reliever ther.: Pts. 18 yrs. and above- 1 inhal. ×2/d. max. dly. dose is 8 inhal.COPD: For pts. 18 yrs. and above- 2 inhal. ×2/d. See lit.
Asthma: Regular tmt. of asthma where use of a combin. product (inhaled corticost.&long-acting β2-agonist) is approp. Pts. not adequate. control. with inhal. corticoster. and ‘as needed’ inhal. rapid-act. beta2-agonist. Pts. already adequat. control. on both inhal. corticoster. and long-act. β2-agonist. COPD :Symptom. tmt. of pts. with severe COPD (FEV1 < 50% predicted normal) and a hist. of repeated exacerb., who have signific. sympt. despite regular ther. with long-act. bronchodilators.
C/I: Hypersens.
Corticosteroid/Beta 2-Agonist. Beclometasone Dipropionate 200mcg/metered dose, Formoterol Fumarate 6mcg/metered dose. INHALER. (Pressurised sol. for inhal).:1×120 actuation.
Adults 18 yrs. and above:
Two inhalations twice dly.
The max. dly. dose is 4 inhalat.
Foster 200/6 should be used as mainten. therapy only. A lower strength (Foster 100/6) is available for mainten. and reliever ther.
Indicated in the regular tmt. of asthma in adult. where use of a comb. product (inhaled corticosteroid and long-act. Β2-ag.) is appropriate:
Pts. not adequate. control. with inhaled corticosteroids and 'as needed' inhaled rapid-acting Β2-agonist.
Pts. already adequat. controlled on both inhaled corticosteroids and long-act. Β2-ag. C/I: Hypersens.
Corticosteroid. Beclometasone Dipropionate 100 mcg. AUTO HALER: 200 actuations x 50 μg,
100 μg. METERED DOSE INHALER:
50 mcg/dose; 100 mcg/dose in canister
contain. 100 or 200 actuats.
New pts: Mild asthma: 100-200 μg/day
in 2 div. doses; mod. asthma: 200-400
μg/day in 2 div. doses; severe asthma:
400-800 μg/day in 2 div. doses. Adults/
maint. dose: See lit. Transfer. pts from a
CFC-contain. inhal; dosing in
wellcontrolled pts with asthma; dosing
in poorly-controlled (symptomat.) pts
with asthma: See lit. Adults/maint.
dose: See lit. Children: > 5yrs: Mildmod.
asthma: 50 μg 2 x dly; severe: 100 μg 2
x dly. Max. dly dose: 100 μg 2 x dly.
Spacing device avail.
Proph. and tmt. bronch. asthma.
C/I: Hypersens.
Corticosteroid. Beclometasone Dipropionate 50 mcg. AUTO HALER: 200 actuations x 50 μg,
100 μg. METERED DOSE INHALER:
50 mcg/dose; 100 mcg/dose in canister
contain. 100 or 200 actuats.
New pts: Mild asthma: 100-200 μg/day
in 2 div. doses; mod. asthma: 200-400
μg/day in 2 div. doses; severe asthma:
400-800 μg/day in 2 div. doses. Adults/
maint. dose: See lit. Transfer. pts from a
CFC-contain. inhal; dosing in
wellcontrolled pts with asthma; dosing
in poorly-controlled (symptomat.) pts
with asthma: See lit. Adults/maint.
dose: See lit. Children: > 5yrs: Mildmod.
asthma: 50 μg 2 x dly; severe: 100 μg 2
x dly. Max. dly dose: 100 μg 2 x dly.
Spacing device avail.
Proph. and tmt. bronch. asthma.
C/I: Hypersens.
Adrenergics in combination with anticholinergics. Beclometasone Dipropionate 100 mcg, Formoterol fumarate dihydrate 6 mcg, Glycopyrronium Bromide 12.5 mcg. INHALER 1X 120 actuat. Pressurised sol. for inhal.
Recomm. and max. dose is two inhal. twice dly.
Pts. should be advised to take this drug every day even when asympt. Not for under 18 years old.
If sympt. arise between doses, inhaled, short-act. beta2-agon. should be used for immed. relief.
Maint. tmt. in adlt. pts. with mod. to sev. chron. obstr. pulm. dis. (COPD) who are not adeq. treat. by a combin. of inhal. corticost. and long-act. beta2-agon. or a combin. of a long-act. beta2-agon. and a long-act. muscar. antagonist.
Maint. tmt. of asthma, in adlts. not adeq. controll. with a maint. combin. of a long-act. beta2-agon. and medium dose of inhal. corticost., and who exper. one or more asthma exacerb. in the prev. year.
C/I: Hypersens.
